search
Back to results

The EAT-On Study: Sensitisation, Allergy and Child Health

Primary Purpose

Food Allergy in Children, Obesity, Childhood, Food Allergen Sensitisation

Status
Unknown status
Phase
Not Applicable
Locations
United Kingdom
Study Type
Interventional
Intervention
Early introduction
Sponsored by
King's College London
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Food Allergy in Children focused on measuring Food allergy, Child Health, Oral tolerance induction, Food allergic sensitisation, Obesity

Eligibility Criteria

7 Years - 8 Years (Child)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Previous participation in the EAT study
  • Age 8 years +/- 12 months

Exclusion Criteria:

  • None

Sites / Locations

  • Paediatric Allergy

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

No Intervention

Arm Label

Early introduction

Standard introduction

Arm Description

Six commonly allergenic foods introduced (in a randomly assigned order) into the diets of exclusively breastfed infants from about 3 months of age.

Infants followed UK DoH standard advice for weaning

Outcomes

Primary Outcome Measures

Allergic sensitisation
Between group differences in total number of cumulative sensitisations to the six study food allergens at age 8
Food allergy
Between group differences in cumulative food allergy (challenge confirmed) t the six study foods at age 8
Child Health
Between group differences in proportion of children who classified as overweight or obese as determined by their BMI and/or BMI z score

Secondary Outcome Measures

Other allergic sensitisations
Between group differences in proportion of children with SPT sensitisation to additional food allergens (hazelnut, brazil nut, cashew, almond and walnut) and aero-allergens (timothy grass, birch pollen, house dust mite, cat and dog dander).
Mechanisms of allergy
Between group differences in specific IgE, IgG and IgG4 to peanut, egg, sesame and aeroallergens
Coeliac disease
Between group differences in prevalence of coeliac disease using coeliac antibody test (tTG IgA) screening test
Atopic dermatitis
Between group differences in prevalence of atopic dematitis
Allergic rhinoconjunctivitis
Between group differences in prevalence of seasonal and perennial rhinoconjunctivitis
Asthma
Between group differences in prevalence of asthma
Oral allergy syndrome
Between group differences in prevalence of oral allergy syndrome
Parent reported food allergy
Between group differences in food reaction history (parent-reported immediate onset food allergy)
Sibling allergies
Prevalence of sibling allergies (food allergies, eczema, asthma and rhinitis)
AGE Level in association with food allergies
Between group differences in AGE levels in association with food allergies
Skin fold thickness
Between group differences in skin fold thickness (triceps and subscapular)
Circumference measurements
Between group differences in midarm, waist and head circumference
Anthropometric ratios
Between group differences in; adjusted weight for height; waist; height ratio; height adjusted weight circumference
Fat free mass
Between group differences in fat free mass
Conicity index
Between group differences in conicity index (calculated from waist circumference and height and weight measurements)
Cardiovascular health
Between group differences in the proportion of children with cardiovascular measurements outside the expected range
Vascular stiffness
Between group differences in vascular stiffness
AGE
Between group differences in advanced glycation end products (AGE)
Inflammation
Between group differences in inflammation (measured using IL=6; sensitive CRP; TNF alpha; MCP-1; RANTES chemokine
Metabolic and endocrine
Between group differences in insulin, IGF-1 and leptin
White cell count
Between group differences in total white blood cell count
Macronutrient dietary intake
Between group differences in macronutrient intake
Dietary habits
Between group differences in fussy eating
Physical activity
Influence of physical activity on anthropometry and body composition measurements
Genetic influences
Influence of parental size on: height; weight; waist circumference on participant's size

Full Information

First Posted
April 4, 2018
Last Updated
April 4, 2018
Sponsor
King's College London
Collaborators
Action Medical Research
search

1. Study Identification

Unique Protocol Identification Number
NCT03495583
Brief Title
The EAT-On Study: Sensitisation, Allergy and Child Health
Official Title
Effects of Early Introduction of Allergenic Foods Followed by Ad-libitum Consumption, on Food Allergic Sensitisation, Allergy and Measures of Child Health at 8 Years of Age in Exclusively Breastfed Infants
Study Type
Interventional

2. Study Status

Record Verification Date
March 2018
Overall Recruitment Status
Unknown status
Study Start Date
April 3, 2018 (Actual)
Primary Completion Date
April 2021 (Anticipated)
Study Completion Date
April 2021 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
King's College London
Collaborators
Action Medical Research

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
The EAT Study showed a reduction in both sensitisation (to all foods) and clinical food allergy (to peanut and egg) among children who consumed allergenic food early compared with those who followed standard government feeding advice to exclusively consume breast milk for the first 6 months of life. The EAT-On Study aims to establish whether the effects seen at 3 years in the EAT study represent a delay in FA onset or sustained tolerance. EAT-On will also investigate the natural history (emergence and resolution) of FA in childhood; thus shaping dietary and management plans for allergic patients. Findings will inform future research and weaning recommendations for preventing FA.
Detailed Description
Sensitisation/Allergy: Food allergy (FA) is common, increasing in prevalence and represents a public health concern in many countries. FA increasingly affects geographic regions where rates of FA were previously low.(1-5) Data from the Enquiring About Tolerance (EAT) study, which enrolled 1303 exclusively breastfed three month old babies from the general population, showed that 8% of children had proven immediate-onset FA at three years of age. This equates to almost 1 in 10 children. (1) The early-introduction of specific food allergen(s) to infant diets is a successful strategy for the prevention of FA. Introduction of peanut to the infant diet before 11 months of age, protected against the development of peanut allergy in a high-risk, atopic population.(6) This effect persisted despite cessation of peanut consumption for 12 months.(7) In the EAT Study, children from the general population were randomised either to consume six commonly allergenic foods (cow's milk, egg, peanut, wheat, fish and sesame) from four months of age (early introduction group (EIG)), or to follow Department of Health (DoH) advice to exclusively breastfeed until about 6 months of age (standard introduction group (SIG)). The per-protocol analysis revealed a reduction in any FA of 7.3% versus 2.4% (p=0.01), for peanut allergy of 2.5% versus 0% (p=0.003) and for egg allergy 5.5% versus 1.4% (p=0.009) in the SIG and EIG respectively. (8) In the EAT study, between 1 and 3 years an intention-to-treat analysis (ITT) of sensitisation to individual foods showed a significant cumulative treatment effect of 35% (p=0.0095) in the EIG (unpublished data). Furthermore, in the per-protocol analyses (PP), we showed a statistically significant reduction of 41.6% (p=0.01) in skin prick test (SPT) sensitivity to any food at 1 year, and again at 3 years with a 67.3% relative reduction (RR) (p=0.002) in the EIG. These findings were particularly significant for individual food; at 3 years there was a relative reduction in skin-prick sensitivity to all individual foods and particularly for peanut (RR 67.1% p=0.007). FA is a dynamic condition with egg and milk allergy typically developing in infancy and being outgrown and peanut and sesame allergy usually developing between the ages of 3-6 and persisting into adulthood. Whilst early introduction of commonly allergenic foods is effective in preventing food allergy in early childhood and within the confines of a randomised controlled trial (RCT), the longevity of this novel approach has not been tested and little is known about whether these effects are sustained after 'real world' ad libitum consumption. The EAT-On Study aims to investigate this by following-up children who were previously enrolled in the EAT Study when they are 8 years of age and investigating the natural history of food allergy, and how the intervention that was applied when children were 4-6 months of age influences food allergic sensitisation and clinical food allergy when they are 8 years of age. Child Health: Whilst the UK Department of Health recommends exclusive breastfeeding (EBF) until around six months of age, surveys suggest this is achieved by only 1% of mothers(9). Given the lack of EBF till 6 months of age, the majority of infants will require additional nutrition provided from formula and/or solid weaning foods. Indeed, 75% of infants have been introduced to solid food by 5 months of age (9). The nutritional consequences of different weaning regimens may have important consequences on obesity outcomes, but rigorous trials in this area are difficult to undertake, not least because of the necessary ethical concerns that pertain to the comparison of breast-feeding with alternate or complementary feeding strategies. The EAT cohort presents a unique opportunity to study this question further as the diet consumed by children who participated in the EIG of the EAT study is much higher in protein than breastmilk alone. Good quality studies have found that consumption of high protein formula milk in early infancy increases the risk of overweight in later childhood compared with breastfeeding, but the effect of high protein solid food consumption alongside breastfeeding in early infancy has not been studied. The majority of infants have solid food introduced before 6 months of age, and updated guidance advocates the introduction of a high protein food (peanut) from 'around 6 months of age' (UK(10) and Australia(11)), or at 4 months of age (USA(12)) to prevent a new onset of peanut allergy. It is therefore timely to explore how early diet, particularly with respect to high protein weaning diet, influences childhood obesity. This will lead to the development of clearer guidance in respect to early weaning diet which extends to other high protein foods, while taking in to account the risk of childhood obesity. The nature of the EAT cohort means that between 4 and 6 months of age children were randomised either to a lower protein diet (SIG) or to a higher protein diet (EIG): breastmilk contains approximately 6% energy from protein whilst the EIG were asked to consume a diet containing at least 15% energy from protein, more than double that of the SIG. This cohort therefore offers a unique opportunity to explore the effect of differing energy consumption from dietary protein on overweight/obesity and markers of cardiovascular health in later childhood.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Food Allergy in Children, Obesity, Childhood, Food Allergen Sensitisation
Keywords
Food allergy, Child Health, Oral tolerance induction, Food allergic sensitisation, Obesity

7. Study Design

Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
Randomised controlled trial in which breastfed infants were randomised (equal groups) either to introduce 6 allergenic foods (cow's milk, egg, wheat, peanut, sesame, fish) from 3 months of age or to continue exclusive breastfeeding until about 6 months of age.
Masking
None (Open Label)
Allocation
Randomized
Enrollment
1235 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Early introduction
Arm Type
Experimental
Arm Description
Six commonly allergenic foods introduced (in a randomly assigned order) into the diets of exclusively breastfed infants from about 3 months of age.
Arm Title
Standard introduction
Arm Type
No Intervention
Arm Description
Infants followed UK DoH standard advice for weaning
Intervention Type
Other
Intervention Name(s)
Early introduction
Intervention Description
Consumption of 2g/week of cow's milk, hen's egg, wheat, peanut, sesame and fish protein from 3 months of age (alongside breastfeeding)
Primary Outcome Measure Information:
Title
Allergic sensitisation
Description
Between group differences in total number of cumulative sensitisations to the six study food allergens at age 8
Time Frame
3 years
Title
Food allergy
Description
Between group differences in cumulative food allergy (challenge confirmed) t the six study foods at age 8
Time Frame
3 years
Title
Child Health
Description
Between group differences in proportion of children who classified as overweight or obese as determined by their BMI and/or BMI z score
Time Frame
3 years
Secondary Outcome Measure Information:
Title
Other allergic sensitisations
Description
Between group differences in proportion of children with SPT sensitisation to additional food allergens (hazelnut, brazil nut, cashew, almond and walnut) and aero-allergens (timothy grass, birch pollen, house dust mite, cat and dog dander).
Time Frame
3 years
Title
Mechanisms of allergy
Description
Between group differences in specific IgE, IgG and IgG4 to peanut, egg, sesame and aeroallergens
Time Frame
3 years
Title
Coeliac disease
Description
Between group differences in prevalence of coeliac disease using coeliac antibody test (tTG IgA) screening test
Time Frame
3 years
Title
Atopic dermatitis
Description
Between group differences in prevalence of atopic dematitis
Time Frame
3 years
Title
Allergic rhinoconjunctivitis
Description
Between group differences in prevalence of seasonal and perennial rhinoconjunctivitis
Time Frame
3 years
Title
Asthma
Description
Between group differences in prevalence of asthma
Time Frame
3 years
Title
Oral allergy syndrome
Description
Between group differences in prevalence of oral allergy syndrome
Time Frame
3 years
Title
Parent reported food allergy
Description
Between group differences in food reaction history (parent-reported immediate onset food allergy)
Time Frame
3 years
Title
Sibling allergies
Description
Prevalence of sibling allergies (food allergies, eczema, asthma and rhinitis)
Time Frame
3 years
Title
AGE Level in association with food allergies
Description
Between group differences in AGE levels in association with food allergies
Time Frame
3 years
Title
Skin fold thickness
Description
Between group differences in skin fold thickness (triceps and subscapular)
Time Frame
3 years
Title
Circumference measurements
Description
Between group differences in midarm, waist and head circumference
Time Frame
3 years
Title
Anthropometric ratios
Description
Between group differences in; adjusted weight for height; waist; height ratio; height adjusted weight circumference
Time Frame
3 years
Title
Fat free mass
Description
Between group differences in fat free mass
Time Frame
3 years
Title
Conicity index
Description
Between group differences in conicity index (calculated from waist circumference and height and weight measurements)
Time Frame
3 years
Title
Cardiovascular health
Description
Between group differences in the proportion of children with cardiovascular measurements outside the expected range
Time Frame
3 years
Title
Vascular stiffness
Description
Between group differences in vascular stiffness
Time Frame
3 years
Title
AGE
Description
Between group differences in advanced glycation end products (AGE)
Time Frame
3 years
Title
Inflammation
Description
Between group differences in inflammation (measured using IL=6; sensitive CRP; TNF alpha; MCP-1; RANTES chemokine
Time Frame
3 years
Title
Metabolic and endocrine
Description
Between group differences in insulin, IGF-1 and leptin
Time Frame
3 years
Title
White cell count
Description
Between group differences in total white blood cell count
Time Frame
3 years
Title
Macronutrient dietary intake
Description
Between group differences in macronutrient intake
Time Frame
3 years
Title
Dietary habits
Description
Between group differences in fussy eating
Time Frame
3 years
Title
Physical activity
Description
Influence of physical activity on anthropometry and body composition measurements
Time Frame
3 years
Title
Genetic influences
Description
Influence of parental size on: height; weight; waist circumference on participant's size
Time Frame
3 years

10. Eligibility

Sex
All
Minimum Age & Unit of Time
7 Years
Maximum Age & Unit of Time
8 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Previous participation in the EAT study Age 8 years +/- 12 months Exclusion Criteria: None
Facility Information:
Facility Name
Paediatric Allergy
City
London
Country
United Kingdom

12. IPD Sharing Statement

Learn more about this trial

The EAT-On Study: Sensitisation, Allergy and Child Health

We'll reach out to this number within 24 hrs